[go: up one dir, main page]

CN100582146C - 生物相容性交联凝胶 - Google Patents

生物相容性交联凝胶 Download PDF

Info

Publication number
CN100582146C
CN100582146C CN200580003963A CN200580003963A CN100582146C CN 100582146 C CN100582146 C CN 100582146C CN 200580003963 A CN200580003963 A CN 200580003963A CN 200580003963 A CN200580003963 A CN 200580003963A CN 100582146 C CN100582146 C CN 100582146C
Authority
CN
China
Prior art keywords
polymer
gel
crosslinking
cross
amount
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
CN200580003963A
Other languages
English (en)
Chinese (zh)
Other versions
CN1918219A (zh
Inventor
劳伦斯·埃尔米特
奥利维尔·贝诺伊特
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Anteis SA
Original Assignee
Anteis SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Anteis SA filed Critical Anteis SA
Publication of CN1918219A publication Critical patent/CN1918219A/zh
Application granted granted Critical
Publication of CN100582146C publication Critical patent/CN100582146C/zh
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08J—WORKING-UP; GENERAL PROCESSES OF COMPOUNDING; AFTER-TREATMENT NOT COVERED BY SUBCLASSES C08B, C08C, C08F, C08G or C08H
    • C08J3/00—Processes of treating or compounding macromolecular substances
    • C08J3/24—Crosslinking, e.g. vulcanising, of macromolecules
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08J—WORKING-UP; GENERAL PROCESSES OF COMPOUNDING; AFTER-TREATMENT NOT COVERED BY SUBCLASSES C08B, C08C, C08F, C08G or C08H
    • C08J3/00—Processes of treating or compounding macromolecular substances
    • C08J3/24—Crosslinking, e.g. vulcanising, of macromolecules
    • C08J3/245—Differential crosslinking of one polymer with one crosslinking type, e.g. surface crosslinking
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/14—Macromolecular materials
    • A61L27/26—Mixtures of macromolecular compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/50—Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials
    • A61L27/52—Hydrogels or hydrocolloids
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08J—WORKING-UP; GENERAL PROCESSES OF COMPOUNDING; AFTER-TREATMENT NOT COVERED BY SUBCLASSES C08B, C08C, C08F, C08G or C08H
    • C08J3/00—Processes of treating or compounding macromolecular substances
    • C08J3/02—Making solutions, dispersions, lattices or gels by other methods than by solution, emulsion or suspension polymerisation techniques
    • C08J3/03—Making solutions, dispersions, lattices or gels by other methods than by solution, emulsion or suspension polymerisation techniques in aqueous media
    • C08J3/075—Macromolecular gels

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Dispersion Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Polymers & Plastics (AREA)
  • Organic Chemistry (AREA)
  • Epidemiology (AREA)
  • Public Health (AREA)
  • Transplantation (AREA)
  • Dermatology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Oral & Maxillofacial Surgery (AREA)
  • Veterinary Medicine (AREA)
  • Materials For Medical Uses (AREA)
  • Medicinal Preparation (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
  • Cosmetics (AREA)
  • Processes Of Treating Macromolecular Substances (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
CN200580003963A 2004-02-03 2005-01-31 生物相容性交联凝胶 Expired - Lifetime CN100582146C (zh)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR0400987 2004-02-03
FR0400987A FR2865737B1 (fr) 2004-02-03 2004-02-03 Gel reticule biocompatible

Publications (2)

Publication Number Publication Date
CN1918219A CN1918219A (zh) 2007-02-21
CN100582146C true CN100582146C (zh) 2010-01-20

Family

ID=34746373

Family Applications (1)

Application Number Title Priority Date Filing Date
CN200580003963A Expired - Lifetime CN100582146C (zh) 2004-02-03 2005-01-31 生物相容性交联凝胶

Country Status (15)

Country Link
US (1) US8052990B2 (es)
EP (1) EP1711552B1 (es)
JP (1) JP5105274B2 (es)
KR (1) KR101044339B1 (es)
CN (1) CN100582146C (es)
AT (1) ATE489420T1 (es)
AU (1) AU2005219595B2 (es)
BR (1) BRPI0507294B8 (es)
CA (1) CA2554597C (es)
DE (1) DE602005024919D1 (es)
ES (1) ES2354699T3 (es)
FR (1) FR2865737B1 (es)
PL (1) PL1711552T3 (es)
RU (1) RU2377260C2 (es)
WO (1) WO2005085329A1 (es)

Families Citing this family (73)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2007038982A1 (en) * 2005-09-27 2007-04-12 Universite Joseph Fourier - Grenoble 1 Hydrogel functionalized with a polymerizable moiety and their uses as biosensors or bioreactors
WO2008034176A1 (en) * 2006-09-19 2008-03-27 Ultraceuticals R & D Pty Ltd Cross-linked polysaccharide gels
FR2909285A1 (fr) * 2006-12-01 2008-06-06 Anteis Sa "utilisation d'un gel anti-adhesif et anti fibrotique"
FR2909560B1 (fr) 2006-12-06 2012-12-28 Fabre Pierre Dermo Cosmetique Gel d'acide hyaluronique pour injection intradermique
US20080287633A1 (en) * 2007-05-18 2008-11-20 Drumheller Paul D Hydrogel Materials
FR2918276B1 (fr) * 2007-07-02 2010-01-22 Anteis Sa "utilisation d'un gel de polysaccharide(s)naturel(s)pour la preparation d'une formulation injectable de traitement des degenerescences articulaires"
FR2918377B1 (fr) 2007-07-05 2010-10-08 Estelle Piron Gel co-reticule de polysaccharides
US20110166530A1 (en) * 2007-07-25 2011-07-07 S & V Technologies Ag Hyaluronic acid dispersion, production and use
TR201901431T4 (tr) 2007-11-16 2019-02-21 Aclaris Therapeutics Inc Purpura tedavisi için bileşimler ve yöntemler.
US8394782B2 (en) 2007-11-30 2013-03-12 Allergan, Inc. Polysaccharide gel formulation having increased longevity
FR2924615B1 (fr) 2007-12-07 2010-01-22 Vivacy Lab Hydrogel cohesif biodegradable.
FR2927255B1 (fr) * 2008-02-07 2011-08-12 Keysan Consulting Produits injectables biocompatibles a liberation de zinc et/ou de sel de saccharide sous forme de zinc et leurs utilisations.
US8574629B2 (en) 2008-08-01 2013-11-05 Anteis S.A. Injectable hydrogel with an enhanced remanence and with an enhanced ability to create volume
US8357795B2 (en) 2008-08-04 2013-01-22 Allergan, Inc. Hyaluronic acid-based gels including lidocaine
WO2010028025A1 (en) 2008-09-02 2010-03-11 Gurtner Geoffrey C Threads of hyaluronic acid and/or derivatives thereof, methods of making thereof and uses thereof
US9339514B2 (en) 2008-09-12 2016-05-17 Aptissen Sa Method for treating glaucoma
US8715266B2 (en) * 2008-09-12 2014-05-06 Aptissen Sa Glaucoma surgery
FR2938187B1 (fr) 2008-11-07 2012-08-17 Anteis Sa Composition injectable a base d'acide hyaluronique ou l'un de ses sels, de polyols et de lidocaine, sterilisee a la chaleur
FR2945293B1 (fr) * 2009-05-11 2011-06-17 Teoxane Procede de preparation d'un gel reticule.
US20110172180A1 (en) 2010-01-13 2011-07-14 Allergan Industrie. Sas Heat stable hyaluronic acid compositions for dermatological use
US8586562B2 (en) 2010-03-12 2013-11-19 Allergan Industrie, Sas Fluid compositions for improving skin conditions
EP3078388B1 (en) 2010-03-22 2019-02-20 Allergan, Inc. Cross-linked hydrogels for soft tissue augmentation
FR2962040B3 (fr) * 2010-07-05 2012-08-10 Alain Villette Composition injectable comprenant un medicament injectable et un gel
US9005605B2 (en) 2010-08-19 2015-04-14 Allergan, Inc. Compositions and soft tissue replacement methods
US8889123B2 (en) 2010-08-19 2014-11-18 Allergan, Inc. Compositions and soft tissue replacement methods
US8883139B2 (en) 2010-08-19 2014-11-11 Allergan Inc. Compositions and soft tissue replacement methods
FR2968305B1 (fr) 2010-12-06 2014-02-28 Teoxane Procede de preparation d'un gel reticule
FR2968996B1 (fr) 2010-12-17 2013-04-12 Anteis Sa Formulation aqueuse injectable sterile utilisee en ophtalmologie
US20140038917A1 (en) 2011-04-19 2014-02-06 Anteis S.A. Sterile and injectable aqueous formulation for administration in the intra-articular space of an intra-articular joint
US20130096081A1 (en) 2011-06-03 2013-04-18 Allergan, Inc. Dermal filler compositions
US9393263B2 (en) 2011-06-03 2016-07-19 Allergan, Inc. Dermal filler compositions including antioxidants
US9408797B2 (en) 2011-06-03 2016-08-09 Allergan, Inc. Dermal filler compositions for fine line treatment
EP3536307B1 (en) 2011-06-03 2021-10-20 ALLERGAN Industrie, SAS Dermal filler compositions including antioxidants
US9662422B2 (en) 2011-09-06 2017-05-30 Allergan, Inc. Crosslinked hyaluronic acid-collagen gels for improving tissue graft viability and soft tissue augmentation
US20130244943A1 (en) 2011-09-06 2013-09-19 Allergan, Inc. Hyaluronic acid-collagen matrices for dermal filling and volumizing applications
KR20210125119A (ko) * 2011-09-14 2021-10-15 알러간, 인코포레이티드 잔주름 치료를 위한 진피 필러 조성물
ITAN20110138A1 (it) 2011-10-12 2012-01-11 Regenyal Lab S R L Sintesi di un gel iniettabile multifasico a base di acido ialuronico monofasico libero e reticolato e di acido ialuronico bifasico associato con idrossiapatite con inibitore della ialuronidasi microincapsulato.
ITMI20120732A1 (it) 2012-05-03 2013-11-04 B S Srl Polisaccaridi reticolati a memoria di forma
FR2991876B1 (fr) 2012-06-13 2014-11-21 Vivacy Lab Composition, en milieu aqueux, comprenant au moins un acide hyaluronique et au moins un sel hydrosoluble de sucrose octasulfate
US9822223B2 (en) 2012-06-15 2017-11-21 Merz Pharma Gmbh & Co. Kgaa Method of preparing a composition based on hyaluronic acid
US20140315828A1 (en) 2013-04-22 2014-10-23 Allergan, Inc. Cross-linked silk-hyaluronic acid compositions
WO2014198406A1 (en) 2013-06-11 2014-12-18 Anteis S.A. Method for crosslinking hyaluronic acid; method for preparing an injectable hydrogel; hydrogel obtained; use of the obtained hydrogel
FR3006689A1 (fr) * 2013-06-11 2014-12-12 Benedicte Vincente Tauzin Procede de reticulation de l'acide hyaluronique; procede de preparation d'un hydrogel injectable; hydrogel obtenu; utilisation de l'hydroget obtenu
JP6479783B2 (ja) * 2013-06-28 2019-03-06 ガルデルマ エス．エー． 架橋ヒアルロン酸生成物を調製するための方法
US10272181B2 (en) 2013-09-27 2019-04-30 Anteis S.A. Method for obtaining an injectable hydrogel based on hyaluronic acid containing lidocaine and an alkaline agent, sterilized with heat
AR099900A1 (es) 2014-04-01 2016-08-24 Merz Pharma Gmbh & Co Kgaa Rellenos para tejidos blandos con polisacáridos con persistencia mejorada, kit, procedimiento, uso
WO2016051219A1 (en) 2014-09-30 2016-04-07 Allergan Industrie, Sas Stable hydrogel compositions including additives
FR3029928B1 (fr) 2014-12-15 2018-03-09 Teoxane Gel reticule
FR3037797B1 (fr) 2015-06-24 2018-08-17 Kylane Laboratoires Sa Procede de preparation d'un hydrogel reticule injectable; hydrogel obtenu; utilisation de l'hydrogel obtenu
WO2017001056A1 (en) * 2015-06-30 2017-01-05 Merz Pharma Gmbh & Co. Kgaa Method for producing crosslinked hyaluronic acid
WO2017001057A1 (en) 2015-06-30 2017-01-05 Merz Pharma Gmbh & Co. Kgaa Method of preparing a composition based on hyaluronic acid
DE102015009271A1 (de) * 2015-07-19 2017-01-19 Tracey Lennemann Neue Verwendung von Hyaluronsäure
ES2856930T3 (es) * 2015-08-13 2021-09-28 Bernard Stoffel Composición para el tratamiento de afecciones articulares
CN108025110B (zh) * 2015-09-09 2021-08-20 苏黎世联邦理工学院 可注射大孔水凝胶
EP3162813A1 (en) 2015-11-02 2017-05-03 Merz Pharma GmbH & Co. KGaA Process for depleting epoxide species in crosslinked poly-saccharide gel compositions and compositions obtained thereby
ES2953928T3 (es) 2015-11-24 2023-11-17 Bmi Korea Co Ltd Composición para la inyección de ácido hialurónico, que contiene un derivado de ácido hialurónico y fracción de ADN, y uso de la misma
FR3044557B1 (fr) 2015-12-07 2017-12-01 Benedicte Vincente Gavard Molliard Tauzin Nouvelle composition injectable; procede de preparation de ladite composition; utilisation de ladite composition
FR3047666A1 (fr) 2016-02-15 2017-08-18 Benedicte Vincente Gavard Molliard Tauzin Composition injectable; procede de preparation de ladite composition; utilisation de ladite composition
TWI727014B (zh) 2016-03-24 2021-05-11 德商梅茲製藥有限兩合公司 修飾透明質酸與其製造方法及其用途
CA2961868A1 (en) * 2016-04-08 2017-10-08 Johnson & Johnson Consumer Inc. Topical compositions containing cross-linked glycosaminoglycans
CA3033536A1 (en) 2016-08-24 2018-03-01 Allergan, Inc. Co-crosslinked hyaluronic acid-silk fibroin hydrogels for improving tissue graft viability and for soft tissue augmentation
CN106397795B (zh) * 2016-08-31 2018-12-21 陕西佰傲再生医学有限公司 一种混合透明质酸凝胶及其制备方法
WO2018083195A1 (en) 2016-11-03 2018-05-11 Merz Pharma Gmbh & Co. Kgaa Method for preparing hyaluronic acid dermal fillers, dermal fillers obtained thereby and their use
PL3538066T3 (pl) 2016-11-11 2022-05-02 Anteis Sa Wypełniacze skórne z kwasem hialuronowym usieciowane kwasem cytrynowym, sposób ich wytwarzania i ich zastosowania
WO2018220283A1 (fr) 2017-05-29 2018-12-06 Kh Medtech Sarl Composition injectable sterile contenant de l'acide hyaluronique reticule et de l'articaine
AU2018391673B2 (en) 2017-12-22 2024-07-11 Galderma Holding SA Injectable gel product
AU2019218711B2 (en) 2018-02-06 2024-12-05 Regen Lab Sa Cross-linked hyaluronic acids and combinations with PRP/BMC
US20190240335A1 (en) * 2018-02-07 2019-08-08 Promedon S.A. Biocompatible Hydrogel Compositions
JP7474239B2 (ja) 2018-08-07 2024-04-24 メルツ ファルマ ゲーエムベーハー ウント コンパニー カーゲーアーアー 架橋ヒドロゲルの動的濾過の方法
LU101045B1 (en) 2018-12-11 2020-06-11 Qventis GmbH Method for the manufacture and use of a bionic hydrogel composition for medical applications
US20230002564A1 (en) 2019-12-09 2023-01-05 Merz Pharma Gmbh & Co. Kgaa Process for producing a composition comprising a crosslinked hydrogel
WO2023275278A1 (en) 2021-06-30 2023-01-05 Merz Pharma Gmbh & Co. Kgaa Hyaluronic acid dermal fillers crosslinked with polyethylene glycol diglycidyl ether, method for making same and uses thereof
CN114470333B (zh) * 2022-03-09 2023-05-23 哈尔滨敷尔佳科技股份有限公司 交联重组胶原蛋白凝胶的制备方法

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5951789A (ja) * 1982-09-18 1984-03-26 Wako Pure Chem Ind Ltd 安定化酵素
US4716224A (en) * 1984-05-04 1987-12-29 Seikagaku Kogyo Co. Ltd. Crosslinked hyaluronic acid and its use
US6174999B1 (en) * 1987-09-18 2001-01-16 Genzyme Corporation Water insoluble derivatives of polyanionic polysaccharides
KR100266912B1 (ko) * 1992-02-28 2000-12-01 파라비 레이 조직접촉물질이며 방출조절운반체인 광중합성 생분해성 하이드로겔
HUT71776A (en) * 1994-03-21 1996-01-29 Ciba Geigy Ag Antibody conjugates with improved properties
EP0713707A1 (en) * 1994-11-23 1996-05-29 Collagen Corporation In situ crosslinkable, injectable collagen composition for tissue augmention
FR2733426B1 (fr) * 1995-04-25 1997-07-18 Debacker Yves Dispositif medical pour le comblement des deformations du volume de la peau telles que rides et cicatrices par injection de 2 formes physico-chimiques differentes d'un polymere biologique
US5827937A (en) * 1995-07-17 1998-10-27 Q Med Ab Polysaccharide gel composition
GB9902652D0 (en) * 1999-02-05 1999-03-31 Fermentech Med Ltd Process
FR2811996B1 (fr) 2000-07-19 2003-08-08 Corneal Ind Reticulation de polysaccharide(s), preparation d'hydrogel(s) ; polysaccharide(s) et hydrogel(s) obtenus,leurs utilisations
WO2002060971A1 (en) * 2001-01-31 2002-08-08 Seikagaku Corporation Crosslinked polysaccharide sponge
US7303814B2 (en) * 2002-02-21 2007-12-04 Encelle, Inc. Immobilized bioactive hydrogel matrices as surface coatings
JP4958368B2 (ja) * 2002-02-28 2012-06-20 電気化学工業株式会社 架橋ヒアルロン酸

Also Published As

Publication number Publication date
RU2377260C2 (ru) 2009-12-27
JP2007520612A (ja) 2007-07-26
ATE489420T1 (de) 2010-12-15
KR101044339B1 (ko) 2011-06-29
CN1918219A (zh) 2007-02-21
ES2354699T3 (es) 2011-03-17
FR2865737B1 (fr) 2006-03-31
FR2865737A1 (fr) 2005-08-05
BRPI0507294A (pt) 2007-07-03
BRPI0507294B8 (pt) 2021-07-27
CA2554597C (fr) 2012-04-24
US20070196426A1 (en) 2007-08-23
EP1711552B1 (fr) 2010-11-24
PL1711552T3 (pl) 2011-04-29
DE602005024919D1 (de) 2011-01-05
EP1711552A1 (fr) 2006-10-18
US8052990B2 (en) 2011-11-08
AU2005219595B2 (en) 2010-07-29
WO2005085329A1 (fr) 2005-09-15
CA2554597A1 (fr) 2005-09-15
BRPI0507294B1 (pt) 2019-02-19
JP5105274B2 (ja) 2012-12-26
RU2006127591A (ru) 2008-02-10
AU2005219595A1 (en) 2005-09-15
KR20070004611A (ko) 2007-01-09

Similar Documents

Publication Publication Date Title
CN100582146C (zh) 生物相容性交联凝胶
CN1829743B (zh) 生物医用的复合基质
JP5883076B2 (ja) 生分解性の単一相結着性親水ゲル
JP6063867B2 (ja) ジスルフィド結合架橋生体適合性高分子ヒドロゲルおよびこれを含む製剤
EP2121026B1 (en) Novel injectable chitosan mixtures forming hydrogels
JP5574083B2 (ja) 高い残留性及び容量を与える高い能力を有する注入可能なヒドロゲル
EP2861626B1 (en) Method of preparing a composition based on hyaluronic acid
JP2023522079A (ja) ヒアルロン酸組成物の制御放出
EP3316911A1 (en) Method of preparing a composition based on hyaluronic acid
US9220807B2 (en) Non-toxic cross-linker for hyaluronic acid
KR20240111814A (ko) 하이드로겔 미립자-기반 연조직 충전제
WO2014169300A1 (en) Non-toxic cross-linker for halyuronic acid
MXPA06008813A (es) Gel entrelazado biocompatible
MXPA06001060A (es) Matriz compleja para uso biomedico

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
C14 Grant of patent or utility model
GR01 Patent grant
CX01 Expiry of patent term
CX01 Expiry of patent term

Granted publication date: 20100120